Clinical Trials Sponsored by Exodus Innovations

Total 1527 results

AO Innovation Translation Center

Terminated

Prospective Multicenter Registry for Use of the MAXFRAME™ Multiaxial Correction System

Deformity of Bone | Limb Deformities Congenital | Limb Deformities Nos (Acquired)

United States, Switzerland
Weprom
Takeda; SIVAN Innovation

Terminated

Relevance of a Web-mediated Follow up in Patients Having a Lymphoma With a High Risk of Relapse in Complete or Partial Response

Lymphoma, Large B-Cell, Diffuse | Lymphoma, T-Cell | Lymphoma, Hodgkin

France
Weprom
SIVAN Innovation Ldt

Completed

SENTINEL : Impact of the Use of a Web-application for the Detection of Lung Cancer Relapse (SENTINEL)

Lung Cancer

France
AO Innovation Translation Center

Recruiting

Fracture Monitor - Femur

Femoral Fracture

Germany
AO Innovation Translation Center

Not yet recruiting

Case Series on the Clinical Performance of VA Clavicle and Clavicle Hook Plate 2.7 Systems

Fracture | Clavicle | Acromioclavicular Joint

Germany, United Kingdom
AO Innovation Translation Center

Recruiting

Fragility Fractures of the Pelvis (FFP)

Pelvic Fracture

Netherlands, Germany, Hong Kong, United States, Canada, Japan, Switzerland
AO Innovation Translation Center

Not yet recruiting

An International, Multicenter, Prospective Registry on Post-traumatic Long Bones Defects

Bone Loss | Limb Fracture

Germany, United States, Korea, Republic of, Netherlands, Switzerland, United Kingdom
AO Innovation Translation Center

Recruiting

Registry to Collect Data on Patients Undergoing Segmental Mandibular Defect Reconstruction Following Oral Squamous Cell Carcinoma Resection

Mandibular Reconstruction | Segmental Mandibular Defects

Germany, Switzerland, United States, Netherlands, Sweden, Spain
New Beta Innovation Limited

Terminated

YQ23 Study in Patients With Critical Limb Ischaemia (YAN)

Critical Limb Ischemia

Hong Kong
New Epsilon Innovation Limited

Active, not recruiting

An Early Phase Study of NEI-01 in Patients With Solid Tumors or Acute Myeloid Leukemia

Advanced Solid Tumor | Relapsed AML | Refractory AML

Hong Kong
AO Innovation Translation Center

Terminated

Trochanter Fixation Nail Advanced (TFNA) Weight Bearing

Femur Fracture

Austria, Switzerland
AO Innovation Translation Center

Terminated

Dynamic Locking Screws 5.0 vs. Standard Locking Screws in Fracture of Distal Femur Treated With Locked Plate Fixation

Distal Femur Fractures

United States, Switzerland, Germany, Austria
AO Innovation Translation Center

Completed

Geriatric Fracture Centers - Evaluation of a Geriatric Co-management Program

Hip Fractures

Singapore, Austria, Thailand, Netherlands, United States, Spain
AO Innovation Translation Center

Completed

MobiChina - A Prospective Multicenter Cohort Study

Hip Fracture | Unstable Fracture

China, Hong Kong
Adan Medical Innovation, SL

Completed

Satisfaction of Patient With Anaphylaxis in the Use of a Medical Device

Anaphylaxis

Spain
Rostrum Medical Innovations Inc.
Medical Initiatives

Not yet recruiting

Evaluation of VQm PHM on Pulmonary Health Parameters for ICU

Stroke | Pneumonia | COPD | Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS) | Ventilators, Mechanical

France, United States, Austria, Czechia
SCRI Development Innovations, LLC
Seagen Inc.

Recruiting

Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer

Breast Cancer

United States
A.M.I. Agency for Medical Innovations GmbH

Recruiting

Safety and Performance of a Silicone Implant for Fecal Incontinence Treatment (SimplyFI)

Fecal Incontinence

Spain, Austria, Germany
Darwin Ang

Recruiting

Rib Fixation for Clinically Severe Rib Fractures From Trauma (SOFRIB)

Flail Chest | Rib Fracture

United States
SCRI Development Innovations, LLC
Incyte Corporation

Terminated

A Study of Itacitinib for the Treatment of Chronic Graft Versus Host Disease (cGVHD)

Chronic Graft-versus-host-disease

United States
SCRI Development Innovations, LLC
Novartis Pharmaceuticals

Completed

A Study of the Hsp90 Inhibitor AUY922 Plus Capecitabine for the Treatment of Patients With Advanced Solid Tumors

Metastatic or Unresectable Solid Tumor Malignancy

United States
SCRI Development Innovations, LLC
Genentech, Inc.

Terminated

Preoperative Chemotherapy and Bevacizumab in Patients With Stage IB (>4 cm), II, or Select Stage III NSCLC

Non-Small Cell Lung Cancer

United States
SCRI Development Innovations, LLC
Celgene Corporation

Completed

Nanoparticle Albumin-Bound (Nab) Paclitaxel/Cyclophosphamide in Early-Stage Breast Cancer

Breast Cancer

United States
Vascular Innovations Co. Ltd.
MedPass International

Completed

Omega™ Left Atrial Appendage (LAA) Occluder in Patients With Non-Valvular Atrial Fibrillation

Atrial Fibrillation

Denmark, Thailand
Boston University
Innovations for Poverty Action

Completed

Evaluation of Novartis Access; a Non-communicable Disease (NCD) Access Initiative

Cardiovascular Disease | Breast Cancer | Asthma | Diabetes Type II
SCRI Development Innovations, LLC
Eisai Inc.

Completed

Trial of Eribulin in Patients Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant Chemotherapy

Metastatic Breast Cancer

United States
Baxter Healthcare Corporation
Synovis Surgical Innovations

Completed

Reinforcement of Surgical Staple Lines Using Peri-Strips Dry (PSD) With Veritas Collagen Matrix (RESULTS)

Obesity

United States
Baxter Healthcare Corporation
Synovis Surgical Innovations

Withdrawn

Rotator Cuff Repair (RCR) With and Without OrthoADAPT Augmentation

Rotator Cuff Tear

United States
Baxter Healthcare Corporation
Synovis Surgical Innovations

Withdrawn

Acute Achilles Repair With or Without OrthADAPT Augmentation

Achilles Tendon Tear

United States
SCRI Development Innovations, LLC
Genentech, Inc.

Completed

Non Small Cell Lung Cancer Patients Treated With Erlotinib Six Months or Longer

Non Small Cell Lung Cancer

United States
SCRI Development Innovations, LLC
Genentech, Inc.

Completed

Trial of Poor Performance Status Patients (ToPPS) (ToPPS)

Non Small Cell Lung Cancer

United States
SCRI Development Innovations, LLC
Celgene Corporation

Completed

Lenalidomide With Gemcitabine in Treatment of Untreated Advanced Carcinoma of the Pancreas

Metastatic Pancreatic Cancer

United States
SCRI Development Innovations, LLC
Genentech, Inc.

Completed

Treatment of Head & Neck Cancer With Chemotherapy and Radiation

Head and Neck Cancer

United States
Baxter Healthcare Corporation
Baxter Innovations GmbH

Completed

Oxidized Cellulose hEmostAsis evaluatioN (OCEAN)

Intra-operative Bleeding

Czech Republic, Germany, Hungary, Poland
SCRI Development Innovations, LLC
Celgene Corporation

Completed

Community Oncology Setting Cost Analysis and Disease Outcomes of Taxane Use in Metastatic Breast Cancer

Metastatic Breast Cancer

United States
SCRI Development Innovations, LLC
Celgene Corporation

Terminated

Thalidomide in Combination With Capecitabine in Patients With Metastatic Breast Cancer

Breast Cancer
SCRI Development Innovations, LLC
Aventis Pharmaceuticals

Completed

Docetaxel Followed by Doxorubicin Plus Cyclophosphamide for Node Positive or High-Risk Primary Breast Cancer

Breast Cancer
Modus Therapeutics AB
University of Oxford

Terminated

Sevuparin/DF02 as an Adjunctive Therapy in Subjects Affected With Uncomplicated Falciparum Malaria

Malaria, Falciparum

Thailand
Mucosa Innovations, S.L.
Universidad de Granada

Completed

Study on the Effects of a Toothpaste in the Microbiome and Clinical Parameters in Patients With Oral Dysbiosis

Oral Dysbiosis

Spain
SCRI Development Innovations, LLC
Sirtex Medical

Completed

Safety Study of Regorafenib and SIR-Spheres® Microspheres Radioembolization in Patients With Refractory Metastatic Colorectal Cancer With Liver Metastases

Colorectal Neoplasms

United States
SCRI Development Innovations, LLC
Novartis Pharmaceuticals

Terminated

LCL161 Plus Topotecan for Patients With Relapsed/Refractory Small Cell Lung Cancer and Select Gynecologic Malignancies

Small Cell Lung Cancer | Ovarian Cancer

United States
Novavax
Coalition for Epidemic Preparedness Innovations

Completed

Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle Vaccine With/Without Matrix-M Adjuvant

COVID-19

United States, Australia
SCRI Development Innovations, LLC
Bayer; Novartis

Completed

Dosing and Effectiveness Study of Sorafenib and RAD001 in the Treatment of Patients With Advanced Kidney Cancer

Kidney Cancer

United States
SCRI Development Innovations, LLC
Genentech, Inc.

Completed

Chemotherapy, Radiation Therapy and Immunotherapy Prior to Surgery in Operable Esophageal Cancer

Esophageal Cancer

United States
SCRI Development Innovations, LLC
Genentech, Inc.

Completed

5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer

Colorectal Cancer | Rectal Cancer | Cancer of the Rectum

United States
Vascular Innovations Co. Ltd.
MedPass International

Active, not recruiting

A Clinical Evaluation of the HYDRA Self Expanding Transcatheter Aortic Valve

Aortic Valve Stenosis

New Zealand, Hong Kong, Thailand, Greece, Lithuania, Poland
SCRI Development Innovations, LLC
Novartis Pharmaceuticals

Completed

Enzalutamide Plus Everolimus in Men With Metastatic Castrate-Resistant Prostate Cancer

Prostate Cancer

United States
Urovant Sciences GmbH
Ion Channel Innovations

Terminated

Safety Study of hMaxi-K Gene Transfer to Treat Overactive Bladder and Detrusor Overactivity

Overactive Bladder

United States
SCRI Development Innovations, LLC
GlaxoSmithKline; Celgene

Withdrawn

Study of Trametinib and Nab-paclitaxel in Patients With Melanoma

Melanoma

United States
Urovant Sciences GmbH
Ion Channel Innovations

Completed

Phase 1 Study With OAB Assessing the Safety and Activity of hMaxi-K Gene Transfer (OAB)

Overactive Bladder

United States

Clinical Trials Sponsored by Exodus Innovations

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bangladesh

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations